Stibbe Advises ORA Shareholder on Sale of Company to IBA

"Stibbe advised the shareholder of ORA (Optimized Radiochemical Applications) on the sale of the company to IBA (Ion Beam Applications S.A., EURONEXT). The transaction pairs ORA’s NEPTIS® radiochemistry technology with IBA’s global footprint to create an integrated solution for hospitals and radiopharmacy networks."

Stibbe represented the shareholder of ORA (Optimized Radiochemical Applications) in the sale of the company to IBA (Ion Beam Applications S.A., EURONEXT). The transaction enables ORA to partner with IBA and accelerate its growth in the fast-evolving field of nuclear medicine. By combining ORA’s NEPTIS® technology with IBA’s global footprint and expertise, the collaboration creates one of the most competitive integrated solutions available to hospitals and radiopharmacy networks worldwide. Stibbe represented the shareholder of ORA with a team composed by: Stefan Odeurs, Nicolas Truyens.

Stibbe Advises ORA Shareholder on Sale of Company to IBA

Read the full story